Michael Okunewitch
Stock Analyst at Maxim Group
(0.53)
# 4,140
Out of 4,575 analysts
384
Total ratings
36.7%
Success rate
-2.3%
Average return
Main Sectors:
Stocks Rated by Michael Okunewitch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Downgraded: Hold | n/a | $7.18 | - | 20 | Jul 17, 2026 | |
| RANI Rani Therapeutics Holdings | Maintained: Buy | $5 | $0.8509 | +487.61% | 15 | Jul 15, 2026 | |
| CMMB Chemomab Therapeutics | Maintained: Buy | $5 | $1.36 | +267.65% | 13 | Jul 13, 2026 | |
| VNRX VolitionRx | Maintained: Buy | $4 | $1.00 | +300.00% | 3 | Jul 7, 2026 | |
| HCWB HCW Biologics | Maintained: Buy | $5 | $2.50 | +100.00% | 24 | Jun 24, 2026 | |
| DFTX Definium Therapeutics | Rated: Buy | $40 → $50 | $43.17 | +15.82% | 15 | Jun 23, 2026 | |
| KPRX Kiora Pharmaceuticals | Maintained: Buy | $12 | $2.55 | +370.59% | 31 | Jun 22, 2026 | |
| CTOR Citius Oncology | Maintained: Buy | $4 | $0.5622 | +611.49% | 12 | Jun 2, 2026 | |
| MDWD MediWound | Maintained: Buy | $30 | $14.23 | +110.82% | 27 | Jun 1, 2026 | |
| BLTE Belite Bio | Maintained: Buy | $200 | $153.36 | +30.41% | 13 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | - | - | 2 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $165 | $129.31 | +27.60% | 23 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 | $1.60 | +337.50% | 12 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $12 → $20 | $11.26 | +77.62% | 11 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 | $1.03 | +191.26% | 15 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.60 | - | 24 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.96 | +237.84% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.21 | +561.16% | 22 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.712 | - | 8 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $10 → $12 | $1.63 | +636.20% | 2 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1 | $0.29 | +244.83% | 23 | Apr 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $3.55 | +322.54% | 7 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $1.08 | - | 6 | Mar 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $0.5203 | - | 28 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.9 | $1.33 | +418.80% | 6 | Sep 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $4.54 | n/a | 1 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 | $0.559 | n/a | 11 | Sep 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.20999999 | n/a | 3 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.792 | n/a | 4 | May 9, 2023 |
AtaiBeckley
Jul 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $7.18
Upside: -
Rani Therapeutics Holdings
Jul 15, 2026
Maintained: Buy
Price Target: $5
Current: $0.8509
Upside: +487.61%
Chemomab Therapeutics
Jul 13, 2026
Maintained: Buy
Price Target: $5
Current: $1.36
Upside: +267.65%
VolitionRx
Jul 7, 2026
Maintained: Buy
Price Target: $4
Current: $1.00
Upside: +300.00%
HCW Biologics
Jun 24, 2026
Maintained: Buy
Price Target: $5
Current: $2.50
Upside: +100.00%
Definium Therapeutics
Jun 23, 2026
Rated: Buy
Price Target: $40 → $50
Current: $43.17
Upside: +15.82%
Kiora Pharmaceuticals
Jun 22, 2026
Maintained: Buy
Price Target: $12
Current: $2.55
Upside: +370.59%
Citius Oncology
Jun 2, 2026
Maintained: Buy
Price Target: $4
Current: $0.5622
Upside: +611.49%
MediWound
Jun 1, 2026
Maintained: Buy
Price Target: $30
Current: $14.23
Upside: +110.82%
Belite Bio
May 27, 2026
Maintained: Buy
Price Target: $200
Current: $153.36
Upside: +30.41%
May 21, 2026
Maintained: Buy
Price Target: $5
Current: -
Upside: -
May 20, 2026
Upgraded: Buy
Price Target: $165
Current: $129.31
Upside: +27.60%
May 18, 2026
Rated: Buy
Price Target: $7
Current: $1.60
Upside: +337.50%
May 15, 2026
Rated: Buy
Price Target: $12 → $20
Current: $11.26
Upside: +77.62%
May 14, 2026
Maintained: Buy
Price Target: $3
Current: $1.03
Upside: +191.26%
May 11, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.60
Upside: -
May 7, 2026
Maintained: Buy
Price Target: $10
Current: $2.96
Upside: +237.84%
May 6, 2026
Maintained: Buy
Price Target: $8
Current: $1.21
Upside: +561.16%
May 4, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.712
Upside: -
Apr 9, 2026
Rated: Buy
Price Target: $10 → $12
Current: $1.63
Upside: +636.20%
Apr 8, 2026
Maintained: Buy
Price Target: $1
Current: $0.29
Upside: +244.83%
Mar 25, 2026
Maintained: Buy
Price Target: $15
Current: $3.55
Upside: +322.54%
Mar 6, 2026
Downgraded: Hold
Price Target: n/a
Current: $1.08
Upside: -
Sep 23, 2025
Maintained: Hold
Price Target: n/a
Current: $0.5203
Upside: -
Sep 13, 2025
Maintained: Hold
Price Target: $6.9
Current: $1.33
Upside: +418.80%
Mar 3, 2025
Maintained: Buy
Price Target: $12
Current: $4.54
Upside: n/a
Sep 13, 2024
Maintained: Buy
Price Target: $12
Current: $0.559
Upside: n/a
Dec 19, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.20999999
Upside: n/a
May 9, 2023
Maintained: Buy
Price Target: n/a
Current: $0.792
Upside: n/a